In patients with migraine who undergo transcatheter closure of patent foramen ovale (PFO), the presence of aura and of residual right-to-left shunt appear to influence the amount of migraine benefits, ...
The first-ever guidelines for interventional cardiologists using percutaneous patent foramen ovale closure recommend expanding the use of the procedure beyond the Food and Drug Administration-approved ...
Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "PFO Closure Device Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. In a landscape shaped by evolving ...
The hypothesis that migraine headaches may be linked to patent foramen ovale (PFO)—meaning PFO closure could be considered as a treatment—is getting renewed support from two new studies that show ...
Please provide your email address to receive an email when new articles are posted on . The Society for Cardiovascular Angiography and Interventions announced it has developed an expert consensus ...
Because the benefits of patent foramen ovale closure were once in question, physicians remain hesitant about its use in clinical practice. Recent data, however, have confirmed the safety and efficacy ...
New guidance from the American Academy of Neurology (AAN) concludes that closure of a common heart defect called a patent foramen ovale (PFO) may be recommended for some people who have had a stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results